iStock.com/JHVEPhoto
Eli Lilly Joins Forces With Amazon Pharmacy for Drug Deliveries
March 14, 2024
Eli Lilly has announced a partnership with Amazon Pharmacy to facilitate the delivery of specific prescription drugs, including the popular weight loss medication Zepbound, directly to patients’ doorsteps through LillyDirect, the drugmaker’s newly established direct-to-consumer platform.
As of Wednesday, Amazon Pharmacy is now able to deliver certain drugs from Eli Lilly that are prescribed for conditions such as obesity, diabetes, or migraines to eligible patients who order them through LillyDirect. This collaboration marks Amazon Pharmacy as the second online pharmacy to join Eli Lilly’s platform, promising two-day deliveries to qualifying patients.
LillyDirect serves as a conduit between patients and an independent telehealth provider, allowing eligible individuals to receive prescriptions online. Moreover, for medications supplied by Eli Lilly, the platform offers a convenient home-delivery option, employing a third-party online pharmacy to fulfill prescriptions directly.
The initiative, launched in January, aims to streamline access to Zepbound and other medications, eliminating the traditional process of visiting a doctor for a prescription and subsequently heading to a pharmacy for fulfillment.
This move by Eli Lilly and Amazon comes amidst a surge in demand for weight loss medications like Zepbound. However, Eli Lilly has grappled with meeting this demand, resulting in intermittent shortages over the past year.
Although Eli Lilly has not disclosed the number of patients utilizing LillyDirect, significant interest has been observed since its inception. The company plans to expand its offerings and partnerships in the future.
Amazon Pharmacy, known for its free two-day deliveries for Prime members, extends this benefit to LillyDirect users as well. This collaboration aims to provide a seamless customer experience with swift delivery times.
In addition to home delivery, Amazon Pharmacy offers access to clinical pharmacists around the clock, providing support and addressing queries regarding prescribed medications.
This collaboration underscores Amazon’s increasing presence in the healthcare sector, following its acquisition of PillPack in 2018 and the subsequent launch of Amazon Pharmacy in 2020. With the landscape of healthcare delivery evolving, partnerships like these are expected to reshape the way patients access essential medications.
Recent News
Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers
Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.
Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue
Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.
Wordle and Worldle Battle Over Names
A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word.
FDA Issues Recall for Crecelac Goat Milk Infant Formula
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.